Clinical Trial Update: VITARIA Registry Study

View source ↗

Summary

The VITARIA Registry Study, sponsored by Cyberonics, for congestive heart failure, is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Cyberonics, Inc. | Conditions: Congestive Heart Failure | Status: SUSPENDED